Hongming Chen

Chief Scientific Officer at Kala Pharmaceuticals, Inc.

Hongming Chen

Hongming Chen

Chief Scientific Officer at Kala Pharmaceuticals, Inc.

Overview
RelSci Relationships

501

Birthday

1971

Age

50

Contact Data
Trying to get in touch with Hongming Chen? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Hongming Chen likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at Living Proof, Inc.

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Accounting Officer, Chief Financial Officer & Treasurer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer & Treasurer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Faculty Director, Lemelson-MIT Program at Massachusetts Institute of Technology

Relationship likelihood: Strong

Head-Investor Relations at Kala Pharmaceuticals, Inc.

Relationship likelihood: Average

Chairman, President & Chief Executive Officer at Primmune Therapeutics, Inc.

Relationship likelihood: Average

Paths to Hongming Chen
Potential Connections via
Relationship Science
You
Hongming Chen
Chief Scientific Officer at Kala Pharmaceuticals, Inc.
Education
BS Chemical Engineering
Class of 1992

The University of Texas at Austin is one of the largest public universities in the United States and is the largest institution of The University of Texas System. Founded in 1883, the university has grown from a single building, eight teachers, two departments and 221 students to a 350-acre main campus with 17 colleges and schools, about 24,000 faculty and staff, and more than 50,000 students.

Graduate

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Memberships
Member
Current

Founded in 1964, the National Academy of Engineering (NAE) is a private, independent, nonprofit institution that provides engineering leadership in service to the nation. The mission of the National Academy of Engineering is to advance the well-being of the nation by promoting a vibrant engineering profession and by marshalling the expertise and insights of eminent engineers to provide independent advice to the federal government on matters involving engineering and technology.

Career History
Chief Scientific Officer
2010 - Current

Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.

Director-Formulation Development
2000 - 2010

TransForm Pharmaceuticals, Inc. develops and manufactures drugs. It integrates pharmaceutical sciences, materials science and high throughput experimentation by enabling novel technology. The company was founded by Nicholas Galakatos in 1999 and is headquartered in Lexington, MA.

Scientist
1997 - 2000

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Transactions
Details Hidden

Kala Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Kala Pharmaceuticals, Inc. raised money in a private placement transaction

Details Hidden

Kala Pharmaceuticals, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Hongming Chen. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Hongming Chen's profile does not indicate a business or promotional relationship of any kind between RelSci and Hongming Chen.